A review of the psychobiology and pharmacotherapy of posttraumatic stress disorder

Canadian Journal of Psychiatry

Volumn 41, Issue 4, 1996, Pages 233-238

  Katz, Laurence ^a   Fleisher, William ^a,b   Kjernlsted, Kevin ^a,b   Milanese, Paul ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

pharmacotherapy; posttraumatic stress disorder; psychobiology

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLONIDINE; DESIPRAMINE; FLUOXETINE; LITHIUM; PHENELZINE; PROPRANOLOL; SERTRALINE;

HUMAN; POSTTRAUMATIC STRESS DISORDER; PSYCHOBIOLOGY; PSYCHOPHARMACOTHERAPY; REVIEW;

EID: 0029941368     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379604100408     Document Type: Review

References (46)

1. Breslau N, Davis GC, Andreski P, Peterson E. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 1991;48:216-22.
2. Davidson JRT, Hughes D, Blazer DG, George LK. Posttraumatic stress disorder in the community: an epidemiological study. Psychol Med 1991:21:713-21.
3. Charney D, Deutch A, Krystal J, Southwick SM, Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 1993;50:295-305.
4. Yehuda R, Resnick H, Kahana B, Giller EL. Longlasting hormonal alterations in extreme stress in humans normative or maladaptive? Psychosom Med 1993;55:287-97.
5. Yehuda R, Giller EL, Levengood RA, and others. Hypothalamic-pituitary-adrenal functioning in PTSD: expanding the concept of the stress response spectrum. In: Friedman MJ, Charney DS, Deutch AW, editors. Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. New York: Raven Press; (in press).
6. Yehuda R, McFarlane A. Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. Am J Psychiatry 1995;152:1705-13.
7. Van der Kolk BA. The drug treatment of posttraumatic stress disorder. J Affect Dis 1987;13:203-13.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
9. Foa E, Riggs D, Gershuny B. Arousal, numbing, and intrusion: symptom structure of PTSD following assault. Am J Psychiatry 1995;152:116-20.
10. Davidson JRT. Drug therapy of posttraumatic stress disorder. Br J Psychiatry 1992;160:309-14.
11. Mesulam M. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 1990;28:597-613.
12. Li D, Spiegel D. A neural network model of dissociative disorders. Psychiatric Annals 1992;22:144-7.
13. Van der Kolk B. The body keeps the score: memory and the evolving psychobiology of post traumatic stress. Harvard Review of Psychiatry 1994;1:253-65.
14. Schwarz ED, Perry BD. The posttraumatic stress response in children and adolescents. Psychiatr Clin North Am 1994;17:311-26.
15. Delaney R, Tussi D, Gold PE. Long-term potentiation as a neurophysiological analog of memory. Pharmacol Biochem Behav 1983;18:137-9.
16. McGaugh JL. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu Rev Neurosci 1989;2:255-87.
17. Gray J. The neuropsychology of anxiety: an inquiry into the functions of the septo-hippocampal system. London: Oxford University Press; 1982.
18. Bills L, Kreisler K. Treatment of flashbacks with naltrexone [letter]. Am J Psychiatry 1993;150:1430.
19. Glover H. A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder. Isr J Psychiatry Relat Sci 1993;30:255-63.
20. Van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, and others. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994;55:517-22.
21. Sutherland SM, Davidson JRT. Pharmacotherapy for posttraumatic stress disorder. Psychiatr Clin North Am 1994;17:409-23.
22. Frank JB, Kosten TR, Giller EL, Dan E. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry 1988;145;1289-91.
23. Reist C, Kauffman CD, Haier RJ, Sangdahl C, DeMet EM, Chicz-DeMet A, and others. A controlled trial of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry 1989;146:513-6.
24. Davidson JRT, Kudler HS, Smith R, Mahomey SL, Lipper S, Hammett E, and others. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 1990;47:259-66.
25. Shestatzky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res 1988;24:149-55.
26. Kudler HS, Davidson JRT, Stein R, Erickson L. Measuring results of treatment of PTSD [letter]. Am J Psychiatry 1989;146:1645-6.
27. Braun P, Greenberg D, Dasberg H, and others. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry 1990;15:236-8.
28. Lipper S, Davidson JRT, Grady TA, Edinger JD, Hammett EB, Mahorney SL, and others. Preliminary study of carbamazepine in posttraumatic stress disorders. Psychosomatics 1986;27:849-54.
29. De Boer M, Op den Velde W, Falger PRJ, Hovens JE, De Groen JHM, Duijn HV, Fluvoxamine treatment for chronic PTSD: a pilot study. Psychother Psychosom 1992;57:158-63.
30. Kline NA, Dow BM, Brown SA, Matloff JL. Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder [letter]. Am J Psychiatry 1994;151:621.
31. Van der Kolk BA, Greenberg M, Orr SP, Pitman RK. Endogenous opioids, stress induced analgesia, and posttraumatic stress disorder. Psychopharmacol Bull 1989;25:417-21.
32. Putnam FW. Dissociation as a response to extreme trauma. In: Kluft RP, editor. The childhood antecedents of multiple personality. Washington (DC): American Psychiatric Press; 1985. p 65-97.
33. Arora RC, Fichtner CG, O'Connor F, and others. Paroxetine binding in the blood platelets of post-traumatic stress disorder patients. Life Sci 1993;53:919-28.
34. Hensman R, Guimaraes FS, Wang M, and others. Effects of ritanserin on aversive classical conditioning in humans. Psychopharmacology 1991;104:220-4.
35. Deakin JFW. Roles of serotonergic systems in escape, avoidance, and other behaviours. In: Cooper SJ, editor. Theory of psychopharmacology. London: Academic Press; 1983. p 149-93.
36. Kosten TR, Frank JB, Dan E, McDougle CJ, Giller EL. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Ner Ment Dis 1991;179:366-70.
37. Nagy LM, Morgan III CA, Southwick SM, Charney DS. Open prospective trial of fluoxetine for posttraumatic stress disorder. J Clin Psychopharmacol 1993;13:107-13.
38. Davidson JRT, Walker JI, Kilts CD. A pilot study of phenelzine in posttraumatic stress disorder. Br J Psychiatry 1987;150:252-5.
39. Kolb LC. Neurophysiological hypothesis explaining posttraumatic stress disorder. Am J Psychiatry 1987;144:989-95.
40. Butler RW, Braff DL, Rausch JL. Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am J Psychiatry 1990;147:1308-12.
41. Shalev AY, Orr SP, Peri T, Schreiber S, Pitman RK. Physiologic responses to loud tones in Israeli patients with post traumatic stress disorder. Arch Gen Psychiatry 1993;49:870-5.
42. Asberg M, Schalling D, Traksman-Bendz L, and others. Psychobiology of suicide, impulsivity, and related phenomena. In: Meltzer HY, editor. Psychopharmacology: the third generation of progress. New York: Raven Press; 1987.
43. Akil H, Watson SJ, Young E. Endogenous opioids: biology and function. Annu Rev Neurosci 1983;7:223-55.
44. Kolb LC, Burris B, Griffith S. Propranolol and clonidine in treatment of the chronic posttraumatic stress disorders of war. In: Van der Kolk BA, editor. Posttraumatic stress disorder: psychological and biological sequelae. Washington (DC): American Psychiatric Association; 1984. p 97-107.
45. Friedman MJ. Toward rational pharmacotherapy for posttraumatic stress disorder: an interim report. Am J Psychiatry 1988;145:281-5.
46. Andreasen NC. Posttraumatic stress disorder: psychology, biology, and the Manichaean warfare between false dichotomies. Am J Psychiatry 1995;152:963-5.